MX2015017549A - Preparacion de rocuronio que causa menos dolor, metodo para producirla, y metodo para reducir y/o aliviar dolor vascular a ser inducido utilizando la misma. - Google Patents
Preparacion de rocuronio que causa menos dolor, metodo para producirla, y metodo para reducir y/o aliviar dolor vascular a ser inducido utilizando la misma.Info
- Publication number
- MX2015017549A MX2015017549A MX2015017549A MX2015017549A MX2015017549A MX 2015017549 A MX2015017549 A MX 2015017549A MX 2015017549 A MX2015017549 A MX 2015017549A MX 2015017549 A MX2015017549 A MX 2015017549A MX 2015017549 A MX2015017549 A MX 2015017549A
- Authority
- MX
- Mexico
- Prior art keywords
- vascular pain
- buffer
- same
- suppressing
- relieving
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se provee una preparación de rocuronio diseñada para reducir dolor vascular a ser inducido. La preparación de rocuronio contiene rocuronio y una solución amortiguadora, y tiene acidez susceptible de ser titulada de 100 mEq o menos. La solución amortiguadora puede ser una solución reguladora de acetato, una solución reguladora de citrato, una solución reguladora de formato, una solución reguladora de tartrato, una solución reguladora de fosfato, una solución reguladora de glicina-ácido clorhídrico, o una solución reguladora de ácido cítrico-fosfato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013138218 | 2013-07-01 | ||
PCT/JP2014/066504 WO2015001995A1 (ja) | 2013-07-01 | 2014-06-23 | 血管痛を改善したロクロニウム製剤及びその製造方法並びに該ロクロニウム製剤を用いた血管痛の抑制・緩和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015017549A true MX2015017549A (es) | 2016-08-04 |
MX366310B MX366310B (es) | 2019-07-04 |
Family
ID=52143574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015017549A MX366310B (es) | 2013-07-01 | 2014-06-23 | Preparacion de rocuronio que causa menos dolor, metodo para producirla, y metodo para reducir y/o aliviar dolor vascular a ser inducido utilizando la misma. |
Country Status (20)
Country | Link |
---|---|
US (1) | US10821119B2 (es) |
EP (1) | EP3017817B1 (es) |
JP (1) | JP5781698B2 (es) |
KR (2) | KR101803857B1 (es) |
CN (2) | CN110251459A (es) |
AU (1) | AU2014285324B2 (es) |
BR (1) | BR112015030877B1 (es) |
CA (1) | CA2914154C (es) |
DK (1) | DK3017817T3 (es) |
ES (1) | ES2794529T3 (es) |
HK (1) | HK1224183A1 (es) |
IL (1) | IL243363B (es) |
MX (1) | MX366310B (es) |
NZ (1) | NZ714485A (es) |
PH (1) | PH12015502850B1 (es) |
PT (1) | PT3017817T (es) |
RU (1) | RU2680405C2 (es) |
SA (1) | SA515370275B1 (es) |
SG (1) | SG11201510733YA (es) |
WO (1) | WO2015001995A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015198456A1 (ja) * | 2014-06-26 | 2015-12-30 | 丸石製薬株式会社 | 安定性を改善したロクロニウム製剤 |
CN111374942B (zh) * | 2018-12-30 | 2022-09-13 | 鲁南制药集团股份有限公司 | 一种甾体类肌松药注射液及其制备方法 |
US20230014293A1 (en) | 2021-07-02 | 2023-01-19 | Fresenius Kabi Austria Gmbh | Aqueous, room-temperature stable rocuronium composition |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8708886D0 (en) | 1987-04-14 | 1987-05-20 | Akzo Nv | 2beta-morpholino-androstane derivatives |
US5418226A (en) * | 1992-04-22 | 1995-05-23 | Akzo N.V. | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
JP2925054B2 (ja) | 1993-08-20 | 1999-07-26 | 宇部興産株式会社 | 疎水性物質の親水性化方法 |
US6030941A (en) * | 1996-05-01 | 2000-02-29 | Avi Biopharma, Inc. | Polymer composition for delivering substances in living organisms |
AU1874499A (en) | 1997-11-27 | 1999-06-16 | Akzo Nobel N.V. | A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administration |
US6911455B2 (en) * | 1999-12-22 | 2005-06-28 | Smithkline Beecham Corporation | Methods for preparing pharmaceutical formulations |
AU2006315610A1 (en) | 2005-11-14 | 2007-05-24 | Peter D. Winch | Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
CN101400369A (zh) * | 2005-11-14 | 2009-04-01 | P·D·温施 | 注射药物及其药学上可接受的盐的新颖的有色溶液 |
EP1967188B1 (en) * | 2005-12-29 | 2012-01-25 | Nipro Corporation | Pharmaceutical preparation of an aqueous solution containing platinum complex |
RU2329799C1 (ru) * | 2006-11-13 | 2008-07-27 | Федеральное государственное учреждение Третий Центральный Военный Клинический госпиталь имени А.А. Вишневского Министерства обороны РФ | Способ анестезии при проведении адреналэктомии по поводу феохромоцитомы надпочечника |
WO2008065142A1 (en) * | 2006-11-29 | 2008-06-05 | N.V. Organon | Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative |
EP2647370B1 (en) | 2010-11-29 | 2019-02-27 | Otsuka Pharmaceutical Factory, Inc. | Infusion preparation |
-
2014
- 2014-06-23 DK DK14820424.1T patent/DK3017817T3/da active
- 2014-06-23 MX MX2015017549A patent/MX366310B/es active IP Right Grant
- 2014-06-23 SG SG11201510733YA patent/SG11201510733YA/en unknown
- 2014-06-23 NZ NZ714485A patent/NZ714485A/en unknown
- 2014-06-23 PT PT148204241T patent/PT3017817T/pt unknown
- 2014-06-23 KR KR1020167002704A patent/KR101803857B1/ko active IP Right Grant
- 2014-06-23 AU AU2014285324A patent/AU2014285324B2/en active Active
- 2014-06-23 BR BR112015030877-5A patent/BR112015030877B1/pt active IP Right Grant
- 2014-06-23 ES ES14820424T patent/ES2794529T3/es active Active
- 2014-06-23 RU RU2016102844A patent/RU2680405C2/ru active
- 2014-06-23 KR KR1020177015581A patent/KR102060160B1/ko active IP Right Grant
- 2014-06-23 US US14/898,259 patent/US10821119B2/en active Active
- 2014-06-23 EP EP14820424.1A patent/EP3017817B1/en active Active
- 2014-06-23 WO PCT/JP2014/066504 patent/WO2015001995A1/ja active Application Filing
- 2014-06-23 CN CN201910588071.0A patent/CN110251459A/zh active Pending
- 2014-06-23 JP JP2014530435A patent/JP5781698B2/ja active Active
- 2014-06-23 CA CA2914154A patent/CA2914154C/en active Active
- 2014-06-23 CN CN201480037714.8A patent/CN105431151A/zh active Pending
-
2015
- 2015-12-14 SA SA515370275A patent/SA515370275B1/ar unknown
- 2015-12-22 PH PH12015502850A patent/PH12015502850B1/en unknown
- 2015-12-27 IL IL243363A patent/IL243363B/en active IP Right Grant
-
2016
- 2016-10-27 HK HK16112421.6A patent/HK1224183A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201809290SA (en) | Compositions and Methods to Treating Hemoglobinopathies | |
MX2016013635A (es) | Métodos para aumentar los niveles de eritrocitos y tratar de la enfermedad de células falciformes. | |
MX2016006220A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea. | |
WO2014113429A3 (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | |
EA201291133A1 (ru) | Антитела, обладающие пониженной иммуногенностью в организме человека | |
MX2014002087A (es) | Formulaciones piretroides. | |
HK1218932A1 (zh) | 酸度上升被抑制了的發酵乳及其製造方法 | |
WO2015127134A3 (en) | Complement component c5 antibodies | |
PT3087178T (pt) | Método para produzir oxalato oxidases que têm atividade ótica próxima ao ph fisiológico e utilização de tais oxalato oxidases recombinantes no tratamento de doenças relacionadas com oxalato | |
WO2016098131A3 (en) | Improved method for the synthesis of ferric oraganic compounds | |
CA3010708A1 (en) | Methods of administering hepcidin | |
WO2014152754A3 (en) | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens | |
PH12015502850A1 (en) | Rocuronium preparation causing less pain, method for producing the same, and method for reducing and/or alleviating vascular pain to be induce using the same | |
WO2014145236A3 (en) | The use of sdf-1 to mitigate scar formation | |
RU2017102325A (ru) | Препарат рокурония с улучшенной стабильностью | |
MX359029B (es) | Procedimiento para el tratamiento de enfermedades relacionadas con el factor inducible por hipoxia (hif) -. | |
WO2016134257A8 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | |
WO2015085055A3 (en) | Methods of treating or preventing pruritis by blocking natriuretic polypeptide b | |
WO2015075062A3 (en) | Method of treating hair | |
IN2013MU01286A (es) | ||
WO2014122638A3 (en) | Thalidomide and thalidomide analogues for the stimulation of stem cell factor | |
WO2014025864A3 (en) | Methods of treating polycystic ovarian syndrome using chlorogenic acid | |
WO2014165736A3 (en) | Esters of 2-deoxy-monosaccharides with anti proliferative activity | |
WO2016108251A3 (en) | Fried snack, a method of preparing the fried snack and a system for preparation thereof | |
MX2019008567A (es) | Metodo de tratamiento post-cosecha utilizando clonostachys rosea. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |